このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Hubei Zhenhua ChemicalLtd マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Yu Sheng Ke

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	0.6%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

Is Hubei Zhenhua ChemicalLtd (SHSE:603067) A Risky Investment?

May 28

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) Surges 31% Yet Its Low P/E Is No Reason For Excitement

Apr 30

CEO（最高経営責任者

Yu Sheng Ke (61 yo)

no data

在職期間

CN¥1,518,800

報酬

Mr. Yu Sheng Ke serves as General Manager and Director at Hubei Zhenhua Chemical Co., Ltd. Mr. Ke is an Engineer.

Hubei Zhenhua ChemicalLtd マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Hubei Zhenhua Chemical Co.,Ltd., Annual General Meeting, Apr 30, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Is Hubei Zhenhua ChemicalLtd (SHSE:603067) A Risky Investment?

Investor sentiment improves as stock rises 18%

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) Surges 31% Yet Its Low P/E Is No Reason For Excitement

First quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.20 in 1Q 2023)

Full year 2023 earnings: EPS misses analyst expectations

Hubei Zhenhua Chemical Co.,Ltd., Annual General Meeting, Apr 30, 2024

Hubei Zhenhua Chemical Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) announces an Equity Buyback for CNY 80 million worth of its shares.

Investor sentiment deteriorates as stock falls 17%

Hubei Zhenhua Chemical Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 10, 2024

Consensus EPS estimates fall by 11%

Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.16 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.28 in 2Q 2022)

Hubei Zhenhua Chemical Co.,Ltd. to Report First Half, 2023 Results on Aug 28, 2023

First quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.20 in 1Q 2022)

Price target increased to CN¥26.54

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.18 in 3Q 2021)

Price target increased to CN¥26.54

Second quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.11 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.12 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.07 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.35 (vs CN¥0.32 in FY 2019)

Hubei Zhenhua Chemical Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day high: CN¥7.54

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) completed the acquisition of Chongqing Minfeng Chemical Co., Ltd. from Chongqing Chemical & Pharmaceutical Holding (Group) Company.

New 90-day low: CN¥6.37

New 90-day low: CN¥6.49

New 90-day high: CN¥7.60

Third quarter earnings released

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) signed an intention agreement to acquire Chongqing Minfeng Chemical Co., Ltd. from Chongqing Chemical & Pharmaceutical Holding (Group) Company for approximately CNY 520 million.

First half earnings released

Hubei Zhenhua Chemical Co.,Ltd. announced a financing transaction

New 90-day high - CN¥8.47

Hubei Zhenhua Chemical Co.,Ltd. to Report First Half, 2020 Results on Aug 21, 2020

CEO（最高経営責任者

在職期間

報酬

マネジメント基準チェック /14